Shandong Sanyuan Biotechnology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shandong Sanyuan Biotechnology Co., Ltd.

Why is Shandong Sanyuan Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -10.28% and Operating profit at -41.22% over the last 5 years

The company has declared negative results in Mar'2025 after 4 consecutive positive quarters

OPERATING PROFIT(Q) Lowest at CNY -4.75 MM
OPERATING PROFIT MARGIN(Q) Lowest at -3 %
PRE-TAX PROFIT(Q) Lowest at CNY 10.8 MM

With ROE of 2.56%, it has a very attractive valuation with a 1.35 Price to Book Value

Over the past year, while the stock has generated a return of -4.83%, its profits have risen by 42.5% ; the PEG ratio of the company is 1.2

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -4.83% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shandong Sanyuan Biotechnology Co., Ltd. should be less than 10%
Overall Portfolio exposure to Chemicals & Petrochemicals should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shandong Sanyuan Biotechnology Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shandong Sanyuan Biotechnology Co., Ltd.

-4.83%

-0.00

41.53%

China Shanghai Composite

16.01%

1.07

14.99%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-10.28%

EBIT Growth (5y)

-41.22%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.49

Sales to Capital Employed (avg)

0.13

Tax Ratio

19.15%

Dividend Payout Ratio

269.23%

Pledged Shares

Institutional Holding

ROCE (avg)

3.47%

ROE (avg)

4.43%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.35

EV to EBIT

128.64

EV to EBITDA

45.85

EV to Capital Employed

1.43

EV to Sales

7.82

PEG Ratio

1.24

Dividend Yield

ROCE (Latest)

1.11%

ROE (Latest)

2.56%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 298.64 MM

DIVIDEND PAYOUT RATIO(Y)

Highest at 1,008.06%

RAW MATERIAL COST(Y)

Fallen by -5.87% (YoY

DIVIDEND PER SHARE(HY)

Highest at CNY 8.3

-13What is not working for the Company

OPERATING PROFIT(Q)

Lowest at CNY -4.75 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -3 %

PRE-TAX PROFIT(Q)

Lowest at CNY 10.8 MM

NET PROFIT(Q)

Lowest at CNY 9.92 MM

EPS(Q)

Lowest at CNY 0.05

Here's what is working for Shandong Sanyuan Biotechnology Co., Ltd.

Operating Cash Flow

Highest at CNY 298.64 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Dividend per share

Highest at CNY 8.3

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend Payout Ratio

Highest at 1,008.06%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by -5.87% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shandong Sanyuan Biotechnology Co., Ltd.

Pre-Tax Profit

At CNY 10.8 MM has Fallen at -63.91%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 9.92 MM has Fallen at -65.91%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Profit

Lowest at CNY -4.75 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -3 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 10.8 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 9.92 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.05

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Non Operating Income

Highest at CNY 1.44 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income